Daiwa Securities Group
ADMA icon

Daiwa Securities Group’s ADMA Biologics ADMA Stock Holding History

Daiwa Securities Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-670
Closed -$12K – 1184
2025
Q4 		$12K Sell
670
-80
-11% -$1.35K ﹤0.01% 1175
2025
Q3 		$11K Sell
750
-108
-13% -$1.85K ﹤0.01% 1153
2025
Q2 		$16K Buy
858
+78
+10% +$1.59K ﹤0.01% 1103
2025
Q1 		$15K Hold
780
– – ﹤0.01% 1079
2024
Q4 		$13K Sell
780
-106
-12% -$1.99K ﹤0.01% 1104
2024
Q3 		$18K Buy
886
+95
+12% +$1.48K ﹤0.01% 1102
2024
Q2 		$9K Hold
791
– – ﹤0.01% 1166
2024
Q1 		$5K Hold
791
– – ﹤0.01% 1201
2023
Q4 		$4K Hold
791
– – ﹤0.01% 1214
2023
Q3 		$3K Hold
791
– – ﹤0.01% 1188
2023
Q2 		$3K Hold
791
– – ﹤0.01% 1211
2023
Q1 		$3K Hold
791
– – ﹤0.01% 1173
2022
Q4 		$3K Buy
791
+205
+35% +$632 ﹤0.01% 1181
2022
Q3 		$1K Hold
586
– – ﹤0.01% 1264
2022
Q2 		$1K Hold
586
– – ﹤0.01% 1272
2022
Q1 		$1K Buy
+586
New +$914 ﹤0.01% 1288
2020
Q4 		– Sell
-335
Closed -$1K – 1254
2020
Q3 		$1K Hold
335
– – ﹤0.01% 1158
2020
Q2 		$1K Hold
335
– – ﹤0.01% 1179
2020
Q1 		$1K Hold
335
– – ﹤0.01% 1181
2019
Q4 		$1K Buy
+335
New +$1.46K ﹤0.01% 1182

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Daiwa Securities Group's ADMA Position: Q1 2026 in Review

Daiwa Securities Group sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 670 shares — an estimated $12K sold.

Daiwa Securities Group first reported a position in ADMA in Q4 2019 and held it in 20 quarters. The position peaked at $18K in Q3 2024. 357 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Daiwa Securities Group reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 670 ADMA Biologics shares in Q1 2026, an estimated $12K.
  • Daiwa Securities Group first reported a position in ADMA Biologics in Q4 2019 and held it in 20 quarters.
  • Daiwa Securities Group's ADMA Biologics position peaked at $18K in Q3 2024.
  • 357 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.